Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/7/2020
NCPA recognizes front-line pharmacists with new video
NCPA CEO Doug Hoey applauds community pharmacists for their efforts in the fight against COVID-19. - 4/7/2020
NACDS' online maps display state-by-state status of action amid COVID-19
NACDS’ online maps show further action is needed to remove barriers to pharmacy patient care immediately. - 4/6/2020
Innovation names Richardson CEO
Innovation co-president Marvin Richardson takes over as CEO on April 25, succeeding Mary Reno, and co-president Tom Boyer will become chief strategy officer. - 4/6/2020
Novartis terminates sale of Sandoz U.S. generic oral solids, dermatology portfolio to Aurobindo
Sandoz will continue to operate its oral solids and dermatology business as part of the Sandoz U.S. business. - 4/6/2020
CVS Health expands COVID-19 testing sites throughout Massachusetts
CVS Health is providing Massachusetts residents with on-the-spot COVID-19 testing and results at no cost, using the new Abbott ID NOW COVID-19 test. - 4/5/2020
CVS Health opens testing sites in 2 states, pop-up pharmacy in New Orleans
CVS Health's rapid COVID-19 drive-through testing sites in Georgia, and Rhode Island will provide on the spot test results, while its pop-up pharmacy in New Orleans will provide maintenance medication and counseling for certain COVID-19 patients. - 4/5/2020
Hy-Vee creates one-way aisle signage, suggests 1 person per cart
Hy-Vee is adding one-way directional aisle signage to maintain six feet of social distancing. - 4/5/2020
NACDS praises new Indiana law as boon for access to pharmacy services
A new Indiana law allows a pharmacist to substitute a therapeutic alternative for epinephrine products. - 4/5/2020
Lupin launches generic Myfortic
Mycophenolic acid delayed-release tablets had a market value of roughly $156 million, according to IQVIA data from February. - 4/5/2020
Lundbeck launches Vyepti
Vyepti is the first and only intravenous treatment for migraine prevention.
